Human toxicology of cyanide

Cyanide in Water and Soil: Chemistry, Risk, and Management

Volumn , Issue , 2005, Pages 237-250

  Borowitz, Joseph L ^a   Isom, Gary E ^a   Nakles, David V ^b  

^a PURDUE UNIVERSITY   (United States)

^b The RETEC Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057899598     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (99)

1. Ballantyne, B., Toxicology of cyanide, in Clinical and Experimental Toxicology of Cyanide, Ballantyne, B. and Marrs, T., Eds., IOP Publishers, Bristol, England, 1987, p. 41.
2. Gee, D., Cyanides in murder, suicide and accident, in Clinical and Experimental Toxicology of Cyanide, Ballantyne, B. and Marrs, T., Eds., IOP Publishers, Bristol, England, 1987, p. 209.
3. DeLorenzo, R.A., Cyanide the deadly terror weapon that everyEMSprovider must knowabout, J. Emerg. Med. Serv., 24, 54, 1999.
4. Rotenberg, J., Cyanide as a weapon of terror, Pediatr. Ann., 32, 236, 2003.
5. Hartung, R., Differential toxicity of forms of cyanide, Aluminum Association, Inc., Washington, D.C., 1990.
6. ATSDR, Toxicological profile for cyanide (update), U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA, 1997.
7. Alarie, Y., Toxicity of fire smoke, Crit. Rev. Toxicol., 32, 259, 2000.
8. Blanc, P., Hogan, M., Mallin, K., Hryhorczuk, D., Hessl, S., and Bernard, B., Cyanide intoxication among silver-reclaiming workers, JAMA, 253, 367, 1985.
9. Hicks, S.P., Brain metabolism in vivo. I. Residual neuropathological effects of cyanide poisoning. Mil. Surgeon, 111, 231, 1950.
10. Bass, N.H., Pathogenesis of myelin lesions in experimental cyanide encephalopathy, Clin. Toxicol., 9, 513, 1968.
11. Ashton, D., Van Reempts, J., and Wauquier, A., Behavioral, electroencephalographic and histological study of the protective effect of etomidate against histotoxic dysoxia produced by cyanide, Arch. Int. Pharmacodyn. Ther., 254, 196, 1981.
12. Funata, N., Song, S.-Y., Okeda, R., Funata, M., and Higashino, F., A study in experimental cyanide encephalopathy in the acute phase-physiological and neuropathological correlation, Acta Neuropathol. (Berl.), 64, 99, 1984.
13. Haymaker, W., Ginzler, A., and Ferguson, R., Residual neuropathological effects of cyanide poisoning, Mil. Surgeon, 111, 231, 1952.
14. Smith, A., Duckett, S., and Waters, A., Neuropathological changes in chronic cyanide intoxication, Nature, 200, 1979, 1963.
15. Gettler, A. and St George, A., Cyanide poisoning, Am. J. Clin. Pathol., 4, 429, 1934.
16. McNamara, B., Estimates of the toxicity of hydrocyanic acid vapors in man, EB-TR-76023, Edgewood Arsenal, Aberdeen Proving Ground, 1976.
17. Soine, W., Brady, K., Balster, R., and Underwood, J., Chemical and behavioral studies of l-piperidinocyclohexane carbonitrile (PCC): evidence for cyanide as the toxic component, Res. Commun. Chem. Pathol. Pharmacol., 30, 59, 1980.
18. Purser, D.A., A bioassay model for testing the incapacitating effects of exposure to combustion product atmospheres using cynomolgus monkeys, J. Fire Sci., 2, 30, 1984.
19. DeMello, G.D., Neuropathological and behavioral sequalae of acute cyanide toxicosis in animal species, in Clinical and Experimental Toxicology of Cyanide, Ballantyne, B. and Marrs, T., Eds., IOP Publishers, Bristol, England, 1987, p. 156.
20. Pavlakovic, G., Rathinavelu, A., and Isom, G.E., MK-801 prevents cyanide-induced changes of Fos levels in rat brain, Neurochem. Res., 19, 1289, 1994.
21. Fechter, L.D., Chen, G.P., and Johnson, D.L., Potentiation of noise-induced hearing loss by low concentrations of hydrogen cyanide in rats, Toxicol. Sci., 66, 131, 2002.
22. Tawakoli, W., Chen, G.D., and Fechter, L.D., Disruption of cochlear potential by chemical asphyxiants: cyanide and carbon monoxide, Neurotoxicol. Teratol., 23, 157, 2001.
23. Gardner, E.A. and Farah, A., The action of some enzyme inhibitors on the isolated rabbit auricle, J. Pharmacol. Exp. Ther., 111, 255, 1954.
24. Kohlhardt, M. and Haap, H., The influence of hypoxia and metabolic inhibitors on the excitation process in atrioventricular node, Basic Res. Cardiol., 75, 712, 1980.
25. Leimdorfer, A., About anoxia of the heart produced by intravenous sodium cyanide injections, Arch. Int. Pharmacodyn. Ther., 84, 181, 1950.
26. Van der Heyden, G., Vereecka, J., and Carmeleit, E., The effect of cyanide on the K-current in guinea pig ventricular myocytes, Basic Res. Cardiol., 80, 93, 1985.
27. + channels in cardiac ischemia: an endogenous mechanism for protection of the heart, Cardiovasc. Drugs Ther., 7, 527, 1993.
28. Borowitz, J.L., Born, G., and Isom, G.E., Potentiation of evoked adrenal catecholamine release by cyanide: possible role of calcium, Toxicology, 50, 37, 1988.
29. Baskin, S.I., Wilkerson, K., and Blitstein, A., Cardiac effects of cyanide, in Clinical and Experimental Toxicology of Cyanide, Ballantyne, B. and Marrs, T., Eds., IOP Publishers, Bristol, England, 1987, p. 138.
30. Yamamoto, H., Effect of atropine on cyanide-induced acute lethality in mice, Toxicol. Lett., 80, 29, 1995.
31. Okolie, N.P. and Osagie, A.V., Liver and kidney lesions and associated enzyme changes induced in rabbits by chronic cyanide exposure, Food Chem. Toxicol., 37, 745, 1999.
32. Borowitz, J.L., Isom, G.E., and Baskin, S.I., Acute and chronic cyanide toxicity, in Chemical Warfare Agents: Toxicity at Low Levels, Somani, S. and Romano, J., Eds., CRC Press, Boca Raton, FL, 2001, p. 301.
33. Carvella, F., Grassi, M., Savoliardo, M., Contri, P., Rapuzzi, B., and Mangoni, A., Dystrophic-Parkinsonian syndrome after cyanide poisoning. Clinical and MRI findings, J. Neurol. Neurosurg. Psych., 51, 1345, 1988.
34. Rosenberg, N., Myers, J., and Martin, W., Cyanide-induced Parkinsonism: clinicalMRIand 6 fluorodopa PET studies, Neurology, 38, 142, 1989.
35. Rosenow, F., Herholz, K., Lanfermann, H., Weuthen, R., and Hess, W., Neurological sequalae of cyanide intoxication—the patterns of clinical, magnetic resonance imaging and positron emission tomography findings, Ann. Neurol., 38, 825, 1995.
36. Utti, R., Rajput, A., Ashenhurst, E., and Rozdilsky, B., Cyanide-induced Parkinsonism: a clinicopathological report, Neurology, 35, 921, 1985.
37. Valenzuela, R., Court, J., and Godoy, S., Delayed cyanide-induced dystonia, J. Neurol. Neurosurg. Psych., 55, 198, 1992.
38. Isom, G.E., Gunasekar, P.G., and Borowitz, J.L., Cyanide and neurodegenerative disease, in Chemicals and Neurodegenerative Disease, Bondy, S., Ed., Prominent Press, Scottsdale, AZ, 1999, p. 101.
39. Jones, D., Prabhakaran, K., Li, L., Gunasekar, P., Shou, Y., Borowitz, J.L., and Isom, G.E., Cyanide enhancement of dopamine-induced apoptosis in mesencephalic cells involves mitochondrial dysfunction and oxidative stress, Neurotoxicology, 24, 333, 2003.
40. Wilson, J., Cyanide in human disease, in Clinical and Experimental Toxicology of Cyanide, Ballantyne, B. and Marrs, T., Eds., IOP Publishers, Bristol, England, 1987, p. 292.
41. Soto-Blanco, B. and Gorniak, S., Milk transfer of cyanide and thiocyanate: cyanide exposure by lactation in goats, Vet. Res., 38, 213, 2003.
42. Soto-Blanco, B., Marioka, P.C., and Gorniak, S., Effects of long term low dose cyanide administration to rats, Ecotoxicol. Environ. Saf., 53, 37, 2002.
43. Anderson, R. and Harland, W., The analysis of volatiles in blood from fire fatalities, in Forensic Toxicology, Oliver, J.S., Ed., Droom Heland, London, 1980, p. 289.
44. Wilson, J., Lebers hereditary optic atrophy: a possible defect in cyanide metabolism, Clin. Sci. Mil. Med., 29, 505, 1965.
45. Stelmaszynska, T. and Zgliczynski, J., The role of myeloperoxidase in phagocytosis, with special regard to HCN formation, in Cyanide in Biology, Vennesland, B., Conn, E., Knowles, C., Westley, J., and Wissing, F., Eds., Academic Press, New York, 1981, p. 371.
46. Solomonson, L.P., Cyanide as a metabolic inhibitor, in Cyanide in Biology, Vennesland, B., Conn, E., Knowles, C., Westley, J., and Wissing, F., Eds., Academic Press, New York, 1981, p. 11.
47. Borowitz, J.L., Gunasekar, P.G., and Isom, G.E., Hydrogen cyanide generation by μ-opiate receptor activation: possible neuromodulatory role of endogenous cyanide, Brain Res., 768, 294, 1997.
48. Gunasekar, P.G., Borowitz, J.L., and Isom, G.E., Endogenous generation of cyanide in neuronal tissue: involvement of a peroxidase system, J. Neurosci. Res., 61, 570, 2000.
49. Gunasekar, P.G., Prabhakaran, K., Li, L., Zhang, L., Isom, G.E., and Borowitz, J.L., Receptor mechanisms mediating cyanide generation in PC12 cells and rat brain, Neurosci. Res., 49, 13, 2004.
50. Brancho, L. and Malvin, G., Thermoregulatory effects of cyanide and azide in the toad, Bufo marinus, Am. J. Physiol., 270, R169, 1996.
51. Wood, J. and Garthwaite, J., Models of the diffusional spread of nitric oxide: implications for nitric oxide signaling and its pharmacological properties, Neuropharmacology, 33, 1235, 1994.
52. Zhang, J. and Snyder, S.H., Nitric oxide in the nervous system, Ann. Rev. Pharmacol. Toxicol., 35, 213, 1995.
53. Kimura, H., Hydrogen sulfide as a neuromodulator, Mol. Neurobiol., 26, 13, 2002.
54. Ewing, J. and Maines, M., Histochemical localization of heme oxygenase-2 protein and mRNA expression in rat brain, Brain Res. Protocols, 1499, 165, 1997.
55. Wang, G. Two’s company, three’s a crowd: Can H2S be the third endogenous gaseous transmitter? FASEB J. 16, 2002, 1792.
56. Isom, G.E. and Baskin, S.I., Enzymes involved in cyanide metabolism, in Comprehensive Toxicology, Vol. 3 of Biotransformation, Guengerich, F.P., Ed., Elsevier Science, Oxford, 1997, p. 477.
57. Al-Qarawi, A., Mousa, H., and Ali, B., Tissue and intracellular distribution of rhodanese and mercaptopyruvate sulfurtransferase in ruminants and birds, Vet. Res., 32, 63, 2001.
58. Nagahara, N., Ito, T., and Minimi, M., Mercaptopyruvate sulfurtransferase as a defense against cyanide intoxication: molecular properties and mode of detoxification, Histol. Pathol., 14, 1277, 1999.
59. Nagahara, N., Ito, T., Kitamura, H., and Nishino, T., Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: confocal laser fluorescence and immunoelectron microscopic studies combined with biochemical analysis, Histochem. Cell Biol., 110, 243, 1998.
60. Purser, D., Grimshaw, P., and Berrill, K., Intoxication by cyanide in fires: a study in monkies using polyacrylonitrile, Arch. Environ. Health, 39, 394, 1984.
61. Baud, F.J., Borron, S., Magarbane, B., Trout, H., Lapostolle, F., Vicaut, E., Debray, M., and Bismuth, C., Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning, Crit. Care Med., 30, 2044, 2002.
62. Hantson, P., Benaissa, L., and Baud, F., Smoke poisoning, Presse Med., 28, 1949, 1999.
63. Kanthasamy, A.G., Borowitz, J.L., and Isom, G.E., Cyanide-induced increases in plasma catecholamines: relationship to acute toxicity, Neurotoxicology, 12, 777, 1991.
64. Kanthasamy, A.G., Maduh, E., Peoples, R., Borowitz, J., and Isom, G., Calcium mediation of cyanide-induced catecholamine release: implications for neurotoxicity, Toxicol. Appl. Pharmacol., 110, 275, 1991.
65. Johnson, J., Meisenheimer, T., and Isom, G.E., Cyanide-induced neurotoxicity: role of neuronal calcium, Toxicol. Appl. Pharmacol., 84, 464, 1986.
66. Persson, A., Cassel, G., and Sellstrom, A., Acute cyanide intoxication and central transmitter systems, Toxicol. Appl. Pharmacol., 5, S150, 1985.
67. Johnson, J.D., Conroy, W.G. and Isom, G.E. Alteration of cytosolic calcium in PC12 cells by potassium cyanide. Toxicol. Appl. Pharmacol., 88, 27, 1987.
68. Gibson, G., Mange, T., Toral-Barza, L., and Freeman, G., Cytosol-free calcium and neurotransmitter release with decreased availability of glucose or oxygen, Neurochem. Res., 14, 437, 1989.
69. Huang, H. and Gibson, G., Phosphatidylinositol metabolism during in vitro hypoxia, J. Neurochem., 52, 830, 1989.
70. Huang, H. and Gibson, G., Effects of in vitro hypoxia on depolarization stimulated accumulation of inositol phosphates in synaptosomes, Life Sci., 45, 1447, 1989.
71. Yang, C.W., Borowitz, J.L., Gunasekar, P. and Isom, G.E., Cyanide-stimulated inositol 1,4,5 trisphosphate formation. An intracellular neurotoxic signaling cascade, J. Biochem Toxicol, 11, 251, 1997.
72. Gunasekar, P.G., Sun, P., Kanthasamy, A., Borowitz, J., and Isom, G.E., Cyanide-induced neurotoxicity involves nitric oxide and reactive oxygen species after N-methyl-D-aspartate receptor activation, J. Pharmacol. Exp. Ther., 277, 150, 1996.
73. +-dependent and independent release of glutamate from mouse brain slices, Neurosci. Lett., 131, 42, 1991.
74. Rossi, D.J., Oshima, T., and Attwell, D., Glutamate release in severe brain ischemia is mainly by reversed uptake, Nature, 203, 316, 2000.
75. Shou, Y., Gunasekar, P., Borowitz, J.L., and Isom, G.E., Cyanide-induced apoptosis involves oxidativestress- activated NFκB in cortical neurons, Toxicol. Appl. Pharmacol., 164, 196, 2000.
76. Li, L., Prabhakaran, K., Shou, Y., Borowitz, J.L., and Isom, G.E., Oxidative stress and cyclooxygenase-2 induction mediate cyanide-induced apoptosis in cortical cells, Toxicol. Appl. Pharmacol., 185, 55, 2002.
77. + homeostasis, Neurosci. Behav. Physiol., 32, 541, 2002.
78. Wang, G. and Thayer, S. NMDA-induced calcium loads recycle across the mitochondrial inner membrane of hippocampal neurons in culture. J. Neurophys., 87, 740, 2002.
79. + influx, J. Neurosci. Res., 63, 377, 2001.
80. Mills, E.M., Gunasekar, P., Li, L., Borowitz, J., and Isom, G.E., Differential susceptibility of brain areas to cyanide involves different modes of cell death, Toxicol. Appl. Pharmacol, 156, 613, 1999.
81. Prabhakaran, K., Li, L., Borowitz, J.L., and Isom, G.E., Cyanide induces different modes of death in cortical and mesencephalon cells, J. Pharmacol. Exp. Ther., 303, 510, 2002.
82. Shou, Y., Li, L., Prabhakaran, K., Borowitz, J.L., and Isom, G.E., P 38 mitogen-activated protein kinase regulates Bax translocation in cyanide-induced apoptosis, Toxicol. Sci., 75, 99, 2003.
83. Busquets, S., Alvarex, B., Van Royen, M., Figueras, T., Lopez-Soriano, F.J., and Argiles, J.M., Increased uncoupling protein-2 gene expression in brain of lipopolysaccharide-injected mice: role of tumour necrosis factor-α, Biochim. Biophys. Acta, 1499, 249, 2001.
84. Richard, D., Rivest, R., Huang, Q., Bouillard, F., Sanchis, D., Champigny, O., and Ricquier, D., Distribution of the uncoupling protein 2 mRNA in the mouse brain, J. Comp. Neurol., 397, 549, 1998.
85. Mills, E.M., Xu, D., Fergusson, M.M., Combs, C.A., Xu, Y., and Finkel, T., Regulation of cellular oncosis by uncoupling protein 2, J. Biol. Chem., 277, 27385, 2002.
86. Bechmann, I., Diano, S., Warden, C.H., Bartfai, T., Nitsch, R.A., and Horvath, T.L., Brain mitochondrial uncoupling protein 2 (UCP2): a protective stress signal in neuronal injury, Biochem. Pharmacol, 64, 363, 2002.
87. Echtay, K.S., Murphy, M.P., Smith, R.A., Talbot, D.A., and Brand, M.D., Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants, J. Biol. Chem., 277, 47129, 2002.
88. Chen, G.R., Ray, R., Dubik, D., Shi, L.F., Cizeau, J., Bleackley, R.C., Saxena, S., Gietz, R.D., and Greenberg, A.H., The E1B 19K Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis, J. Exp. Med., 186, 1975, 1997.
89. Guo, K., Searfoss, G., Krolikowski, D., Pagnoni, M., Franks, C., Clark, K., Yu, K.T., Jaye, M., and Ivashchenko, Y., Hypoxia induces the expression of the pro-apoptotic gene BNIP3, Cell Death Different, 8, 367, 2001.
90. Sowter, H.M., Ratcliffe, P.J., Watson, P., Greenberg, A.H., and Harris, A.L., HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors, Cancer Res., 61, 6669, 2001.
91. Vande Velde, C., Cizeau, J., Dubik, D., Alimonti, J., Brown, T., Israels, S., Hakem, R., and Greenberg, A.H., BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore, Mol. Cell. Biol., 20, 5454, 2000.
92. Ray, R., Chen, G., Vande Velde, C., Cizeau, J., Park, J.H., Reed, J.C., Gietz, R.D., and Greenberg, A.H., BNIP3 heterodimerizes with Bcl-2/Bcl-XL and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites, J. Biol. Chem., 275, 1439, 2000.
93. Pearce, L., Bominaar, E., Hill, B., and Peterson, J., Reversal of cyanide inhibition of cytochrome c oxidase by the auxiliary substrate nitric oxide: an endogenous antidote to cyanide poisoning, J. Biol. Chem., 278, 52139, 2003.
94. Sun, P., Borowitz, J.L., Kanthasamy, A., Kane, M., Gunasekar, P.G., and Isom, G.E., Antagonism of cyanide toxicity by isosorbide dinitrate: possible role of nitric oxide, Toxicology, 104, 105, 1995.
95. Burrows, G. and Way, J.L., Cyanide intoxication in sheep: antagonism with sodium nitrite, cobalt chloride and sodium thiosulfate, Am. J. Vet. Res., 40, 613, 1979.
96. Berlin, C., The treatment of cyanide poisoning in children, Pediatrics, 6, 793, 1970.
97. Sauer, S.W. andKeim, M.E., Hydroxocobalamin: improved public health readiness for cyanide disasters, Ann. Emerg. Med., 37, 635, 2001.
98. Bhattacharya, R. and Vijayaragharan, R., Promising role of alpha-ketoglutarate in protecting against the lethal effects of cyanide, Hum. Exp. Toxicol., 21, 297, 2002.
99. Borron, S.W. and Baud, F.J., Acute cyanide poisoning: clinical spectrum, diagnosis and treatment, Arh. Hig. Rada. Toksikol., 47, 307, 1996.